| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |